-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DKToIcdssUOyagTrrsYGXCtpL8zASlePRHRnbSShCjTEilAq8WCuWjxo8c/u4m5t /fEJrInunuaxGixV/qfq3Q== 0001193125-04-024081.txt : 20040217 0001193125-04-024081.hdr.sgml : 20040216 20040217070629 ACCESSION NUMBER: 0001193125-04-024081 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040217 GROUP MEMBERS: PATRICK SOON-SHIONG GROUP MEMBERS: STEVEN H. HASSAN GROUP MEMBERS: THEMBA TRUST SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ CENTRAL INDEX KEY: 0001141399 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680389419 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78076 FILM NUMBER: 04602296 BUSINESS ADDRESS: STREET 1: 1101 PERIMETER DRIVE STREET 2: SUITE 300 CITY: SCHAUMBURG STATE: IL ZIP: 60173-5837 BUSINESS PHONE: 847-969-2700 MAIL ADDRESS: STREET 1: 1101 PERIMETER DRIVE STREET 2: SUITE 300 CITY: SCHAUMBURG STATE: IL ZIP: 60173-5837 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN PHARMACEUTICAL PARTNERS INC /CA/ DATE OF NAME CHANGE: 20010525 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN BIOSCIENCE INC CENTRAL INDEX KEY: 0001064768 IRS NUMBER: 954486088 STATE OF INCORPORATION: CA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 2730 WILSHIRE BLVD 110 CITY: SANTA MONICA STATE: CA ZIP: 90403 BUSINESS PHONE: 3108833145 MAIL ADDRESS: STREET 1: 2730 WILSHIRE BLVD 110 CITY: SANTA MONICA STATE: CA ZIP: 90403 SC 13G/A 1 dsc13ga.htm AMENDMENT 1 TO SCHEDULE 13G Amendment 1 to Schedule 13G

OMB APPROVAL


OMB Number:

   3235-0145

Expires:

   October 31, 2002

Estimated average burden

hours per response . . . 14.9


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 13G

 

 

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

 

 

 

American Pharmaceutical Partners, Inc.


(Name of Issuer)

 

 

Common Stock


(Title of Class of Securities)

 

 

02886P 10 9


                                (CUSIP Number)                                

 

 

December 31, 2003


(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

 

¨ Rule 13d-1(c)

 

x Rule 13d-1(d)

 

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No.    02886P 10 9

 


  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

            American Bioscience, Inc. (“ABI”)

            95-4486088

   

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨

(b)  x

   

  3.  

SEC Use Only

 

   

  4.  

Citizenship or Place of Organization

 

            California

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  5.    Sole Voting Power

 

                47,984,160


  6.    Shared Voting Power

 

                47,984,160


  7.    Sole Dispositive Power

 

                47,984,160


  8.    Shared Dispositive Power

 

                47,984,160


  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

            47,984,160*

   

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares.

 

            Not applicable

 

 

¨


11.  

Percent of Class Represented by Amount in Row (9)

 

            68.8%

   

12.  

Type of Reporting Person (See Instructions)

 

            CO

   

 

* Except that Themba Trust and Steven H. Hassan may be deemed to have shared power to vote and dispose of, and Dr. Soon-Shiong may be deemed to have shared power to vote and dispose of these shares.


CUSIP No.    02886P 10 9

 


  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

            Themba Trust

   

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨

(b)  x

   

  3.  

SEC Use Only

 

   

  4.  

Citizenship or Place of Organization

 

            Themba Trust is established under the laws of the Isle of Man.

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  5.    Sole Voting Power

 

                0


  6.    Shared Voting Power

 

                47,984,160


  7.    Sole Dispositive Power

 

                0


  8.    Shared Dispositive Power

 

                47,984,160


  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

            47,984,160**

   

10.  

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

 

            Not applicable

 

 

¨


11.  

Percent of Class Represented by Amount in Row (9)

 

            68.8%

   

12.  

Type of Reporting Person (See Instructions)

 

            OO

   

 

** Includes 47,984,160 shares of common stock of the issuer directly owned by ABI. Themba Trust is the record holder of a majority of the outstanding capital stock of ABI, and may be deemed to have shared power to vote and dispose of the shares directly owned by ABI.


CUSIP No. 02886P 10 9

 


  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

            Steven H. Hassan

   

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨

(b)  x

   

  3.  

SEC Use Only

 

   

  4.  

Citizenship or Place of Organization

 

            United States

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  5.    Sole Voting Power

 

                0


  6.    Shared Voting Power

 

                47,984,160


  7.    Sole Dispositive Power

 

                0


  8.    Shared Dispositive Power

 

                47,984,160


  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

            47,984,160***

   

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

            Not applicable.

 

 

¨


11.  

Percent of Class Represented by Amount in Row (9)

 

            68.8%

   

12.  

Type of Reporting Person (See Instructions)

 

            IN

   

 

*** Includes 47,984,160 shares held by ABI. Mr. Hassan is a trustee of Themba Trust with primary control over its assets, and may be deemed to have shared power to vote and dispose of the shares directly held by ABI. Corporate Management & Business Services Limited, an Isle of Man organization, has secondary control over the assets held by Themba Trust as co-trustee.


CUSIP No. 02886P 10 9

 


  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

            Patrick Soon-Shiong

   

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨

(b)  x

   

  3.  

SEC Use Only

 

   

  4.  

Citizenship or Place of Organization

 

            United States

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  5.    Sole Voting Power

 

                346,875


  6.    Shared Voting Power

 

                48,734,160


  7.    Sole Dispositive Power

 

                346,875


  8.    Shared Dispositive Power

 

                48,734,160


  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

            49,081,035****

   

10.  

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

 

            Not applicable.

 

¨

 


11.  

Percent of Class Represented by Amount in Row (9)

 

            70.3%

   

12.  

Type of Reporting Person (See Instructions)

 

            IN

   

 

**** Includes (i) 339,375 shares of common stock purchasable under stock options held by Dr. Soon-Shiong, (ii) 7,500 shares of common stock directly owned by Dr. Soon-Shiong, (iii) 750,000 shares of common stock held in trusts for the benefit of family members of Dr. Soon-Shiong, over which Dr. Soon-Shiong may be deemed to share voting and dispositive power, and (iv) 47,984,160 shares directly held by ABI. Dr. Soon-Shiong is the President and Chairman of the Board of Directors of ABI, and in such capacity may be deemed to have shared power to dispose of the shares directly owned by ABI. Dr. Soon-Shiong and his spouse are also beneficiaries of the Themba Trust.


Item 1.

 

(a)

   Name of Issuer          
         American Pharmaceutical Partners, Inc.          
   

(b)

   Address of Issuer’s Principal Executive Offices          
        

11777 San Vicente Blvd., Suite 550

Los Angeles, CA 90049

         

Item 2.

 

(a)

   Name of Person Filing          
         This Schedule 13G is being filed on behalf of the following persons (the “Reporting Persons”):          
              i.    American BioScience, Inc.          
              ii.    Themba Trust          
              iii.    Steven H. Hassan          
              iv.    Patrick Soon-Shiong          
        

Themba Trust is the record holder of a majority of the capital stock of ABI, and may be deemed to have indirect beneficial ownership of the shares directly owned by ABI. Dr. Soon-Shiong and his spouse are beneficiaries of Themba Trust.

 

Mr. Hassan is a trustee of Themba Trust with primary control over its assets, and may be deemed to have indirect beneficial ownership of the shares directly held by ABI. Corporate Management & Business Services Limited, an Isle of Man organization, has secondary control over the assets held by Themba Trust as co-trustee.

 

Dr. Soon-Shiong is the President and Chairman of the Board of Directors of ABI, and as such may be deemed to have indirect beneficial ownership of the shares directly owned by ABI. Dr. Soon-Shiong and his spouse are trustees of certain family trusts, and as such may be deemed to share voting and dispositive power over shares held in such trusts for the benefit of his family members.

 

Themba Trust and Mr. Hassan hereby disclaim indirect beneficial ownership of shares directly owned by ABI except to the extent of any indirect pecuniary interest therein. Dr. Soon-Shoing hereby disclaims indirect beneficial ownership of the shares held in trusts for the benefit of his family members, except to the extent of his pecuniary interest therein. In his capacity as shareholder of ABI, Dr. Soon-Shiong hereby disclaims indirect beneficial ownership of the shares directly owned by ABI except to the extent of his pecuniary interest therein.


     (b)    Address of Principal Business Office or, if none, Residence          
          The principal business office of ABI and Dr. Soon-Shiong is located at 2730 Wilshire Boulevard, #110, Santa Monica, California 90403.          
          The principal business address of Themba Trust and Mr. Hassan is 10182 Culver Boulevard, Culver City, California 90232.          
     (c)    Citizenship          
          i    American BioScience, Inc. is a California corporation.          
          ii    Themba Trust is a trust organized under the laws of the Isle of Man.          
          iii    Steven H. Hassan is a United States citizen.          
          iv    Patrick Soon-Shiong is a United States citizen.          
     (d)    Title of Class of Securities          
               Common Stock, par value $0.001 per share.          
     (e)    CUSIP Number          
               02886P 10 9          

Item 3.

   If this statement is filed pursuant to §§240.13d-l(b) or 240.13d-2(b) or (c), check whether the person filing is a:     
    

Not  applicable.

    

Item 4.

   Ownership.     
The information in item 1 and items 5 through 11 on the cover pages (pp. 2 – 5) on this Schedule 13G is provided as of December 31, 2003 and is hereby incorporated by reference into this item 4. On August 8, 2003, the board of directors of the issuer declared a three-for-two stock split that was effected by means of a stock dividend for stockholders of record as of August 18, 2003 and which was paid on September 2, 2003. All share and per share amounts set forth herein have been adjusted to reflect the three-for-two stock split.          

Item 5.

   Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.          

Item 6.

   Ownership of More than Five Percent on Behalf of Another Person.          
     Not applicable.          

Item 7.

   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.          
     Not applicable.          

 


Item 8.

   Identification and Classification of Members of the Group.          
     Not applicable.          

Item 9.

   Notice of Dissolution of Group          
     Not applicable.          

Item 10.

   Certification          


SIGNATURES

 

After reasonable inquiry and to the best knowledge and belief of the undersigned, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

Dated: February 11, 2004

 

AMERICAN BIOSCIENCE, INC.

By:  

/s/    Patrick Soon-Shiong

   
    Patrick Soon-Shiong
    President

 

 

THEMBA TRUST

By:  

/s/    Steven H. Hassan

   
    Steven H. Hassan
    Trustee

 

 

By:  

/s/    Steven H. Hassan

   
    Steven H. Hassan

 

 

By:  

/s/    Patrick Soon-Shiong

   
    Patrick Soon-Shiong
-----END PRIVACY-ENHANCED MESSAGE-----